Your browser is no longer supported. Please, upgrade your browser.
Settings
NVS Novartis AG daily Stock Chart
NVS [NYSE]
Novartis AG
Index- P/E15.47 EPS (ttm)5.68 Insider Own9.30% Shs Outstand2.58B Perf Week1.33%
Market Cap226.34B Forward P/E15.90 EPS next Y5.53 Insider Trans-0.06% Shs Float2.52B Perf Month-0.60%
Income13.33B PEG2.21 EPS next Q1.30 Inst Own11.60% Short Float0.06% Perf Quarter6.15%
Sales52.67B P/S4.30 EPS this Y15.20% Inst Trans0.25% Short Ratio0.57 Perf Half Y11.81%
Book/sh33.67 P/B2.61 EPS next Y6.29% ROA9.70% Target Price100.00 Perf Year1.41%
Cash/sh5.71 P/C15.39 EPS next 5Y7.00% ROE17.90% 52W Range72.30 - 94.19 Perf YTD2.40%
Dividend2.98 P/FCF41.21 EPS past 5Y-3.50% ROI7.10% 52W High-6.60% Beta0.76
Dividend %3.39% Quick Ratio1.00 Sales past 5Y-0.70% Gross Margin67.40% 52W Low21.68% ATR1.49
Employees125000 Current Ratio1.20 Sales Q/Q3.40% Oper. Margin28.00% RSI (14)56.76 Volatility0.77% 1.33%
OptionableYes Debt/Eq0.41 EPS Q/Q-21.30% Profit Margin25.40% Rel Volume0.72 Prev Close87.87
ShortableYes LT Debt/Eq0.29 EarningsJan 23 BMO Payout47.20% Avg Volume2.83M Price87.97
Recom- SMA202.93% SMA500.72% SMA2006.88% Volume1,188,456 Change0.12%
Jan-02-19Downgrade JP Morgan Neutral → Underweight
Dec-11-18Resumed Jefferies Buy
Oct-09-18Initiated Guggenheim Neutral
Sep-10-18Upgrade BofA/Merrill Underperform → Buy
May-29-18Downgrade HSBC Securities Buy → Hold
May-25-18Upgrade Credit Suisse Underperform → Neutral
Jan-25-18Reiterated Leerink Partners Outperform $93 → $100
Dec-06-17Downgrade BofA/Merrill Neutral → Underperform
Jul-26-17Upgrade Morgan Stanley Underweight → Overweight
Jul-05-17Downgrade Credit Suisse Neutral → Underperform
Mar-09-17Initiated Liberum Buy
Mar-08-17Upgrade Societe Generale Hold → Buy
Mar-07-17Downgrade Exane BNP Paribas Neutral → Underperform
Jan-11-17Downgrade Credit Suisse Outperform → Neutral
Nov-10-16Upgrade Argus Hold → Buy
Oct-10-16Reiterated Chardan Capital Markets Buy $95 → $92
Sep-20-16Initiated Chardan Capital Markets Buy $95
Apr-12-16Downgrade Morgan Stanley Equal-Weight → Underweight
Mar-23-16Downgrade Leerink Partners Outperform → Mkt Perform
Jun-22-15Upgrade Bryan Garnier Neutral → Buy
Jan-16-19 10:16AM  Tilray Teams Up With Authentic Brands, Stock Down on Sell-Off Zacks
09:25AM  6 Reasons Why You Should Buy Eli Lilly (LLY) Stock in 2019 Zacks
Jan-15-19 04:18PM  Here's How The Government Shutdown Will Affect These Medical Stocks Investor's Business Daily
Jan-14-19 04:02PM  Tilray Shares Rally as Investor Plans Not to Sell Shares Zacks
Jan-11-19 06:11PM  NASH Space in Focus in 2019 as Firms Look to Diversify Zacks
12:02PM  Will Tilrays Dealmaking Lift Tilray Stock in 2019? InvestorPlace
10:38AM  Puma Biotech (PBYI) Down More Than 40% in 90 Days: Here's Why Zacks
09:45AM  Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet Zacks
Jan-10-19 06:05AM  Novartis migraine drug not cost effective - U.K. price watchdog Reuters
Jan-09-19 02:01PM  Canopy Growth Moves to Key Resistance Investopedia
08:31AM  Novartis' Crizanlizumab Gets Breakthrough Therapy Status Zacks
Jan-08-19 10:11AM  Novartis Stock Is Poised to Rise Another 15% From Here TheStreet.com
08:15AM  The Daily Biotech Pulse: Amgen Slashes Cholesterol Drug Device Prices By 60%, Takeda Completes Shire Purchase Benzinga
Jan-07-19 06:59PM  Cramer Remix: This chipmaker could have another bad quarterbut it's worth buying now CNBC
06:40PM  Novartis CEO on chasing cures over profitable treatments CNBC Videos
06:24PM  Novartis CEO talks chasing cures over profitable treatments, says they will 'ultimately' be valued CNBC
Jan-04-19 06:32PM  Tilray Gains More Than 200%: Is There More Scope for Growth? Zacks
04:24PM  These Stocks Pop After FDA Expedites Review Of Gene-Editing Therapy Investor's Business Daily
Jan-03-19 05:58PM  Verily lines up $1 billion investment American City Business Journals
03:49PM  Bristol-Myers' (BMY) Sprycel Gets FDA Nod for Label Expansion Zacks
10:27AM  Ironwood/Allergan Settle Linzess Patent Litigation With Mylan Zacks
10:12AM  Will Pfizer's (PFE) Stock Keep Up the Momentum in 2019? Zacks
Dec-31-18 08:31AM  Novartis (NVS) Benefits From New Drugs & Key Acquisitions Zacks
Dec-28-18 05:40PM  Conatus (CNAT) Focuses on Developing NASH Candidate Emricasan Zacks
Dec-27-18 09:39AM  Teva Stock Rises on Patent Settlement With Neos Therapeutics Zacks
08:20AM  Forget J&J, Buy These 3 Big Drug Stocks Instead in 2019 Zacks
Dec-24-18 10:08AM  Jazz (JAZZ) Falls as Sleep Drug Gets Extended Review From FDA Zacks
Dec-23-18 11:31AM  What Are the Best Marijuana Stocks? Motley Fool
Dec-21-18 04:26PM  Why Gene Therapy Is More Cost Effective Than Biogen's Approved Drug Investor's Business Daily
08:51AM  Novartis (NVS) Offers to Buy French Gene Therapy Manufacturer Zacks
Dec-20-18 09:44PM  U.S body says gene therapy may be more cost effective for spinal muscular atrophy Reuters
07:29PM  U.S body says gene therapy may be more cost effective for spinal muscular atrophy Reuters
05:20PM  Tilray CEO still thinks his cannabis company could be worth $100 billion even with the extreme stock market volatility Yahoo Finance
01:42PM  Commentary: GSK, Pfizer and GE shift away from diversification in latest round of health-care deals CNBC
09:20AM  Novartis oncology boss Barrett makes quick exit Reuters
07:53AM  The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum Benzinga
06:00AM  Is Tilray Stock a Must-Buy Following New Partnership? InvestorPlace
01:51AM  Novartis appoints Susanne Schaffert to lead oncology business Reuters
Dec-19-18 08:08PM  Major pharma companies plan to raise drug prices in January: report MarketWatch
07:48PM  Exclusive: Big Pharma returning to U.S. price hikes in January after pause Reuters
07:28PM  Exclusive: Big Pharma returning to U.S. price hikes in January after pause Reuters
04:30PM  Tilray shares surge after announcing $100 million deal with AB InBev to study cannabis-based beverages CNBC
10:23AM  Aduro Stock Surges on STING Activator Deal With Eli Lilly Zacks
09:36AM  Tilray Stock Up on Medical Cannabis Collaboration With Sandoz Zacks
09:30AM  Company News For Dec 19, 2018 Zacks
09:25AM  Glaxo, Pfizer to Merge Consumer Health Units, Form New JV Zacks
08:05AM  Novartis, China's Gan & Lee push into insulin amid diabetes epidemic Reuters
07:26AM  Novartis links with China's Gan & Lee in global insulin push Reuters
Dec-18-18 06:14PM  Tilray shares soar on deal with Novartis. Here's what it ... CNBC Videos
04:12PM  Tilray Jumps After Canadian Pot Stock Signs Deal With Novartis Investor's Business Daily
01:56PM  What's In Store for GE in 2019? & Tuesday's Trending Stocks: TLRY, JNJ, ORCL Zacks
12:20PM  Why Tilray Is Jumping Today Motley Fool
11:51AM  Tilray Partners with Novartis in Big Pharmas First Deal of Its Kind with Big Marijuana Barrons.com
11:20AM  Tilray Shares Surge on Novartis Distribution Deal TheStreet.com
10:30AM  Tilray Shares Jump On The Back Of Novartis Partnership Benzinga
10:20AM  Puma Biotech's Nerlynx Ups Survival in Third-Line Breast Cancer Zacks
10:16AM  Tilray partners with Novartis in Big Pharmas first deal of its kind with Big Marijuana MarketWatch
09:50AM  Teva Reports Positive Top-Line Data for Migraine Candidate Zacks
09:47AM  Alkermes, Biogen Submit NDA to FDA for Multiple Sclerosis Drug Zacks
09:36AM  Cannabis company Tilray shares jump 11% after announcing deal with Swiss drugmaker Novartis CNBC
09:23AM  J&J Okays $5B Stock Buyback Plan, Stock Remains Stressed Zacks
Dec-17-18 05:29PM  Roche's SMA Candidate Risdiplam Gets PRIME Designation in EU Zacks
02:53PM  Incyte (INCY) Collaborates with Innovent for 3 Candidates Zacks
Dec-16-18 09:07AM  2 Sets of Disasters Biotech Will Pay For in 2019 Motley Fool
Dec-14-18 09:28AM  Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? Zacks
08:19AM  Pharma Stock Roundup: AZN, RHHBY Cancer Drugs, LLY, BMY New Deals in Focus Zacks
07:05AM  Today's Research Reports on Trending Tickers: Bristol-Myers Squibb and Novartis ACCESSWIRE
Dec-13-18 10:13AM  J&J's Tremfya Beats Novartis' Cosentyx in Head-to-Head Study Zacks
07:56AM  The Daily Biotech Pulse: Vivus Extends Supply Deal With Sandoz, Applied Genetic Snaps Ties With Biogen Benzinga
Dec-12-18 04:13PM  J&J says its psoriasis drug superior to Novartis treatment in study Reuters
07:05AM  J&J says its psoriasis drug superior to Novartis' in study Reuters
Dec-11-18 03:03PM  Teva (TEVA) Stock Poised to Record Big Gains in 2019? Zacks
08:22AM  The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings Benzinga
Dec-10-18 11:44PM  Here is What Hedge Funds Think About Novartis AG (NVS) Insider Monkey
09:13AM  Amgen (AMGN) Continues to Reward Shareholders, Ups Dividend Zacks
Dec-06-18 11:33PM  Generic drugmaker Sandoz to sell alternative to EpiPen injectors MarketWatch
07:19PM  Novartis to launch Adamis' EpiPen rival in U.S. next year Reuters
02:51PM  Conatus' Emricasan Misses Primary Endpoint in Mid-Stage Study Zacks
02:49PM  Roche's Kadcyla Halves Death Risk in Breast Cancer Study Zacks
Dec-05-18 08:45AM  Roche's Tecentriq Combination Gets Priority Review by FDA Zacks
Dec-04-18 05:25PM  Incyte (INCY) Announces Positive Data on Jakafi for GVHD Zacks
03:58PM  Gilead (GILD) Announces Data on CAR T Therapy Candidate Zacks
09:12AM  FDA Accepts BLA & Gives Priority Review to Novartis' AVXS-101 Zacks
08:13AM  Global Blood Therapeutics' Voxelotor on Faster Approval Path Zacks
07:41AM  Glaxo to Sell India's Popular Horlicks Brand to Unilever Zacks
03:52AM  Novartis's new treatment for hives outperforms Xolair in trials Reuters
Dec-03-18 01:32PM  UPDATE 1-High-cost Gilead cell therapy proves durable for some lymphoma patients Reuters
01:46AM  Novartis SMA treatment could get FDA approval in May Reuters
Dec-02-18 06:57PM  High-cost Gilead cell therapy proves durable for some lymphoma patients Reuters
Nov-30-18 04:16PM  Pfizer Stock Edges Into Buy Zone On AbbVie Deal For Humira Biosimilar Investor's Business Daily
04:14PM  This Biotech Stock Could Launch Its First CRISPR Drug In 2022 Investor's Business Daily
03:19PM  Novartis' Gilenya Approved in EU for Expanded Population Zacks
03:12PM  Novartis CEO Has One New Breakthrough Drug: It Costs $4 Million Meredith Videos
Nov-29-18 10:11AM  Teva's Rituxan Biosimilar Gets FDA Nod in Non-Hodgkin Lymphoma Zacks
08:38AM  Roche (RHHBY) to Acquire Jecure and Enter the NASH Space Zacks
08:10AM  4 Big Pharma Stocks to Add to Your Portfolio in December Zacks
Nov-28-18 05:48PM  Novartis (NVS) Receives EC Approval for Neulasta Biosimilar Zacks
04:07PM  Celgene & Bluebird's CAR T Therapy Study Completes Enrollment Zacks
02:30PM  Novartis' Biosimilar to Amgen's Neulasta Approved in Europe GuruFocus.com
08:34AM  Novartis joins rush of science companies moving to White City Evening Standard
Novartis AG researches, develops, manufactures, and markets a range of healthcare products worldwide. The company's Innovative Medicines segment offers patented prescription medicines to enhance health outcomes for patients and health-care providers. This segment also commercializes products in the areas of oncology and rare diseases, ophthalmology, immunology and dermatology, neuroscience, respiratory, cardio-metabolic, and established medicines. The Sandoz segment provides active ingredients and finished dosage forms of pharmaceuticals in the areas of cardiovascular, central nervous system, dermatology, gastrointestinal and hormonal therapies, metabolism, oncology, ophthalmic, pain, and respiratory; active pharmaceutical ingredients and intermediates primarily antibiotics; protein or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. The Alcon segment offers eye care products, such as eye care devices for cataract, retinal, glaucoma, and refractive surgery, as well as intraocular lenses to treat cataracts and refractive errors; viscoelastics, surgical solutions, surgical packs, and other disposable products for cataract and vitreoretinal surgery; and contact lenses, as well as contact lens care products, including multi-purpose and hydrogen-peroxide based solutions, rewetting drops, and daily protein removers. Novartis AG has collaboration agreements with Xencor; QIAGEN N.V.; Surface Oncology; Intellia Therapeutics; Caribou Biosciences; Bristol-Myers Squibb; IBM Watson Health; Amgen; Allergan plc; Science 37, Inc.; Bill & Melinda Gates Foundation; PEAR Therapeutics; Pfizer; and Conatus Pharmaceuticals Inc. Novartis AG was founded in 1895 and is headquartered in Basel, Switzerland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Novartis Bioventures Ltd10% OwnerAug 20Sale2.3020,38846,8922,396,882Aug 22 04:34 PM
Novartis Bioventures Ltd10% OwnerAug 20Sale3.905,30020,6705,800,250Aug 22 04:07 PM
Novartis Bioventures Ltd10% OwnerAug 17Sale2.108,70018,2702,417,270Aug 20 05:12 PM
Novartis Bioventures Ltd10% OwnerAug 16Sale2.108,80818,4972,425,970Aug 20 05:12 PM
Novartis Bioventures Ltd10% OwnerAug 15Sale2.152,6355,6652,434,778Aug 16 04:18 PM
Novartis Bioventures Ltd10% OwnerAug 14Sale2.263,3007,4582,437,413Aug 16 04:18 PM
Novartis Bioventures Ltd10% OwnerAug 13Sale2.361,6003,7762,440,713Aug 14 05:05 PM
Novartis Bioventures Ltd10% OwnerAug 10Sale2.445,61513,7012,442,313Aug 14 05:05 PM
Novartis Bioventures Ltd10% OwnerAug 09Sale2.482355832,447,928Aug 10 04:29 PM
Novartis Bioventures Ltd10% OwnerAug 08Sale2.781,0002,7802,448,163Aug 10 04:29 PM
Novartis Bioventures Ltd10% OwnerAug 07Sale2.971,7395,1652,449,163Aug 08 04:21 PM
Novartis Bioventures Ltd10% OwnerAug 06Sale3.022,9428,8852,450,902Aug 08 04:21 PM
Novartis Bioventures Ltd10% OwnerAug 02Sale3.334,70215,6582,453,844Aug 06 04:22 PM
Novartis Bioventures Ltd10% OwnerAug 01Sale3.228,18126,3432,458,546Aug 02 04:33 PM
Novartis Bioventures Ltd10% OwnerJul 31Sale3.074,50013,8152,466,727Aug 02 04:33 PM
Novartis Bioventures Ltd10% OwnerJul 30Sale3.272,0006,5402,471,227Jul 31 04:16 PM
Novartis Bioventures Ltd10% OwnerJul 27Sale3.386,45821,8282,473,227Jul 31 04:16 PM
Novartis Bioventures Ltd10% OwnerJul 26Sale3.637,93728,8112,479,685Jul 27 04:21 PM
Novartis Bioventures Ltd10% OwnerJul 25Sale3.8412,46047,8462,487,622Jul 27 04:21 PM
Novartis Bioventures Ltd10% OwnerJul 24Sale4.117002,8772,500,082Jul 25 04:35 PM
Novartis Bioventures Ltd10% OwnerJul 23Sale4.2530,600130,0502,500,782Jul 25 04:35 PM
Novartis Bioventures Ltd10% OwnerJul 17Sale4.7112,50058,8752,531,382Jul 18 04:17 PM
Novartis Bioventures Ltd10% OwnerJul 16Sale5.153001,5452,543,882Jul 18 04:17 PM
Novartis Institutes for BioMed10% OwnerApr 23Buy15.00766,66611,499,9903,948,482Apr 23 04:43 PM